The previous page is sending you to https://www.farmaindustria.es/web/otra-noticia/los-nuevos-tratamientos-para-esclerosis-multiple-generan-beneficios-a-los-pacientes-y-ahorros-a-los-sistemas-sanitarios/.

 If you do not want to visit that page, you can return to the previous page.